These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 19181672)

  • 1. Clinical, histological and genetic characterization of reducing body myopathy caused by mutations in FHL1.
    Schessl J; Taratuto AL; Sewry C; Battini R; Chin SS; Maiti B; Dubrovsky AL; Erro MG; Espada G; Robertella M; Saccoliti M; Olmos P; Bridges LR; Standring P; Hu Y; Zou Y; Swoboda KJ; Scavina M; Goebel HH; Mitchell CA; Flanigan KM; Muntoni F; Bönnemann CG
    Brain; 2009 Feb; 132(Pt 2):452-64. PubMed ID: 19181672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial reducing body myopathy with cytoplasmic bodies and rigid spine revisited: identification of a second LIM domain mutation in FHL1.
    Schessl J; Columbus A; Hu Y; Zou Y; Voit T; Goebel HH; Bönnemann CG
    Neuropediatrics; 2010 Feb; 41(1):43-6. PubMed ID: 20571991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel FHL1 mutation in a family with reducing body myopathy.
    Schreckenbach T; Henn W; Kress W; Roos A; Maschke M; Feiden W; Dillmann U; Schulz JB; Weis J; Claeys KG
    Muscle Nerve; 2013 Jan; 47(1):127-34. PubMed ID: 23169582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consequences of mutations within the C terminus of the FHL1 gene.
    Schoser B; Goebel HH; Janisch I; Quasthoff S; Rother J; Bergmann M; Müller-Felber W; Windpassinger C
    Neurology; 2009 Aug; 73(7):543-51. PubMed ID: 19687455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel mutation in FHL1 in a family with X-linked scapuloperoneal myopathy: phenotypic spectrum and structural study of FHL1 mutations.
    Chen DH; Raskind WH; Parson WW; Sonnen JA; Vu T; Zheng Y; Matsushita M; Wolff J; Lipe H; Bird TD
    J Neurol Sci; 2010 Sep; 296(1-2):22-9. PubMed ID: 20633900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic heterogeneity in British patients with a founder mutation in the FHL1 gene.
    Sarkozy A; Windpassinger C; Hudson J; Dougan CF; Lecky B; Hilton-Jones D; Eagle M; Charlton R; Barresi R; Lochmüller H; Bushby K; Straub V
    Eur J Hum Genet; 2011 Oct; 19(10):1038-44. PubMed ID: 21629301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FHL1-related myopathy may not be classified by reducing bodies in muscle biopsy.
    Chen T; Lu X; Shi Q; Guo J; Wang H; Wang Q; Yin X; Zhang Y; Pu C; Zhou D
    Neuromuscul Disord; 2020 Feb; 30(2):165-172. PubMed ID: 32001145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal muscle biopsy analysis in reducing body myopathy and other FHL1-related disorders.
    Malfatti E; Olivé M; Taratuto AL; Richard P; Brochier G; Bitoun M; Gueneau L; Laforêt P; Stojkovic T; Maisonobe T; Monges S; Lubieniecki F; Vasquez G; Streichenberger N; Lacène E; Saccoliti M; Prudhon B; Alexianu M; Figarella-Branger D; Schessl J; Bonnemann C; Eymard B; Fardeau M; Bonne G; Romero NB
    J Neuropathol Exp Neurol; 2013 Sep; 72(9):833-45. PubMed ID: 23965743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing body myopathy associated with the LIM2 p.(His123Arg) FHL1 variant.
    Darki L; Jalali-Sohi A; Guzman S; Mathew AJ; Bucelli RC; Hurth KM; Beydoun SR
    Clin Neurol Neurosurg; 2021 Aug; 207():106795. PubMed ID: 34273663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing body myopathy and other FHL1-related muscular disorders.
    Schessl J; Feldkirchner S; Kubny C; Schoser B
    Semin Pediatr Neurol; 2011 Dec; 18(4):257-63. PubMed ID: 22172421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Childhood reducing body myopathy caused by FHL1 gene variation in a child].
    Wei CJ; Wang ZX; Chang XZ; Lyu JL; Ge L; Fan YB; Zhang YH; Xiong H
    Zhonghua Er Ke Za Zhi; 2020 Feb; 58(2):147-149. PubMed ID: 32102154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An X-linked myopathy with postural muscle atrophy and generalized hypertrophy, termed XMPMA, is caused by mutations in FHL1.
    Windpassinger C; Schoser B; Straub V; Hochmeister S; Noor A; Lohberger B; Farra N; Petek E; Schwarzbraun T; Ofner L; Löscher WN; Wagner K; Lochmüller H; Vincent JB; Quasthoff S
    Am J Hum Genet; 2008 Jan; 82(1):88-99. PubMed ID: 18179888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic identification of FHL1 as the protein mutated in human reducing body myopathy.
    Schessl J; Zou Y; McGrath MJ; Cowling BS; Maiti B; Chin SS; Sewry C; Battini R; Hu Y; Cottle DL; Rosenblatt M; Spruce L; Ganguly A; Kirschner J; Judkins AR; Golden JA; Goebel HH; Muntoni F; Flanigan KM; Mitchell CA; Bönnemann CG
    J Clin Invest; 2008 Mar; 118(3):904-12. PubMed ID: 18274675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FHL1-mutated reducing body myopathy.
    Lim KY; Kim HH; Sung JJ; Oh BM; Kim K; Park SH
    Neuropathology; 2020 Apr; 40(2):185-190. PubMed ID: 31803991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing bodies and myofibrillar myopathy features in FHL1 muscular dystrophy.
    Selcen D; Bromberg MB; Chin SS; Engel AG
    Neurology; 2011 Nov; 77(22):1951-9. PubMed ID: 22094483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing body myopathy - A new pathogenic FHL1 variant and literature review.
    Mota IA; Correia CDC; Fontana PN; Carvalho AAS
    Neuromuscul Disord; 2021 Sep; 31(9):847-853. PubMed ID: 34366191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fhl1 W122S causes loss of protein function and late-onset mild myopathy.
    Emmanuele V; Kubota A; Garcia-Diaz B; Garone C; Akman HO; Sánchez-Gutiérrez D; Escudero LM; Kariya S; Homma S; Tanji K; Quinzii CM; Hirano M
    Hum Mol Genet; 2015 Feb; 24(3):714-26. PubMed ID: 25274776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Dominant C150Y Mutation in FHL1 Induces Structural Alterations in LIM2 Domain Causing Protein Aggregation In Human and Drosophila Indirect Flight Muscles.
    Santhoshkumar R; Preethish-Kumar V; Mangalaparthi KK; Unni S; Padmanabhan B; T S KP; Nongthomba U; Atchayaram N; Narayanappa G
    J Mol Neurosci; 2021 Nov; 71(11):2324-2335. PubMed ID: 33515430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exome Sequencing Identified a Splice Site Mutation in FHL1 that Causes Uruguay Syndrome, an X-Linked Disorder With Skeletal Muscle Hypertrophy and Premature Cardiac Death.
    Xue Y; Schoser B; Rao AR; Quadrelli R; Vaglio A; Rupp V; Beichler C; Nelson SF; Schapacher-Tilp G; Windpassinger C; Wilcox WR
    Circ Cardiovasc Genet; 2016 Apr; 9(2):130-5. PubMed ID: 26933038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FHL1 mutants that cause clinically distinct human myopathies form protein aggregates and impair myoblast differentiation.
    Wilding BR; McGrath MJ; Bonne G; Mitchell CA
    J Cell Sci; 2014 May; 127(Pt 10):2269-81. PubMed ID: 24634512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.